sebastiantombs
Known around here
My comment is that "double blind studies" over periods of years are the best way to go. Unfortunately, that isn't practical under the current set of circumstances. Additionally, "anecdotal" data can be quite valuable, especially when large numbers of report are available. Yes, it makes "fine analysis" much harder, but if we had waited with any number of drugs, penicillin being one of them, how many more deaths would have occurred? Also, consider that the "dangerous" drug hydroxychlorquine is not, technically, FDA approved for use in lupus treatment, but it is routinely prescribed for that illness with the blessings of the medical community. Hypocrisy seems to exist in the medical field as well.
From the reports I have seen, Ivermectin, if administered immediately after a positive test result the symptoms were reduced, sometimes very significantly, when compared to people who didn't take it. Yes, anecdotal, but the number of reported successes with it are mounting and it is being used, with safety and success, here in the US as well. That Nature article painted it like it's grasping at straws to try it, but how did hydroxychlorquine get used for Lupus except by grasping at straws.
From the reports I have seen, Ivermectin, if administered immediately after a positive test result the symptoms were reduced, sometimes very significantly, when compared to people who didn't take it. Yes, anecdotal, but the number of reported successes with it are mounting and it is being used, with safety and success, here in the US as well. That Nature article painted it like it's grasping at straws to try it, but how did hydroxychlorquine get used for Lupus except by grasping at straws.
Last edited: